77 products of 59 pharmaceutical factories were stopped using in Jiangxi Province, which failed to pass the consistency evaluation.

On September 16, Jiangxi drug centralized purchase platform released the notice on adjusting the online purchase qualification of clindamycin and other drugs According to the 2015 implementation plan for centralized purchase of drugs in public hospitals in Jiangxi Province and the opinions on the evaluation of the quality and efficacy of generic drugs issued by the general office of the State Council, those who have passed the evaluation are suspended If the product fails to pass the conformity evaluation, the online procurement qualification shall be restored after passing the conformity evaluation At present, the list of drugs suspended from purchasing includes 77 drugs of different specifications, which are respectively from 59 drug manufacturers Among them, Chengdu Tongde Pharmaceutical Co., Ltd., Jiangsu Dahongying Hengshun Pharmaceutical Co., Ltd and Chongqing Dikang Changjiang Pharmaceutical Co., Ltd all three drugs have been stopped from purchasing The loss in this action is relatively large This article is reprinted by yaozhi.com The copyright belongs to the original author The purpose of reprint is to transmit more information, which does not represent the view of this platform If the content of the work, copyright and other issues are involved, please contact our website message, we will delete the content in the first time.